Showing results (981-990 of 1,200) with videos related to

Sort By:
Pageof 120
The American Journal of Gastroenterology|July 4, 2009
Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practiceAngel Lanas, Luis A García-Rodríguez, Mónica Polo-Tomás, et al.
Gigascience|May 3, 2013
Quantifying the use of bioresources for promoting their sharing in scientific researchLaurence Mabile, Raymond Dalgleish, Gudmundur A Thorisson, et al.
The Journal of Infectious Diseases|February 15, 2023
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1Eva Poveda, Wendy Fitzgerald, Cristina Reglero, et al.
Skeletal Muscle|March 2, 2025
OBSCN undergoes extensive alternative splicing during human cardiac and skeletal muscle developmentAli Oghabian, Per Harald Jonson, Swethaa Natraj Gayathri, et al.
European Journal of Human Genetics : EJHG|January 8, 2015
Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failureMaria Andrea Desbats, Annalisa Vetro, Ivan Limongelli, et al.
Plos One|January 14, 2020
Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probabilityPaula E North, Emily Ziegler, Donna K Mahnke, et al.
Biochemical and Biophysical Research Communications|September 6, 2018
Pigment epithelium derived factor (PEDF) expression in the male tract of Wistar ratsMaria Ines Conte, Maria Eugenia Cabrillana, Tania Estefania Saez Lancellotti, et al.
Medicine and Science in Sports and Exercise|February 6, 2002
Diagnosing external iliac endofibrosis by postexercise ankle to arm index in cyclistsBenjamin Fernández-García, Javier Alvarez Fernández, Florentino Vega García, et al.
Chemmedchem|April 24, 2010
Gene therapy in HIV-infected cells to decrease viral impact by using an alternative delivery methodTeresa Gonzalo, Maria Isabel Clemente, Louis Chonco, et al.
European Cytokine Network|May 21, 2010
Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirinMaria Angeles Jimenez-Sousa, Raquel Almansa, Concha de la Fuente, et al.
Pageof 120